agilon health, inc. (AGL) Cash flow
Market cap
$37.4B
P/E ratio
| 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 15 | 14 | 20 | 24 |
| Stock-based compensation | 292 | 28 | 69 | 51 |
| Cash from operations | -148 | -131 | -156 | -58 |
| Capital expenditures | -7 | -15 | -16 | -13 |
| Cash from investing | -91 | -444 | -44 | 140 |
| Proceeds from issuance of term debt, net | 100 | - | - | - |
| Repayments of term debt | 120 | 5 | 5 | 4 |
| Cash from financing | 1,154 | 28 | -193 | -3 |
| Free cash flow | ||||
| FCF margin (%) |